1 顾觉奋.海南三叶药业集团研制成青霉素Ⅴ钾片填补 国内空白.海南医学, 1996, 1:62
2 杨泉玲.青霉素Ⅴ钾.中国新药杂志, 1994, 3(4):20
3 Wade WG, Bishop P. In vitro activity of meropenem and other agents against oral bacteria. Chemo therapy, 1992, 38:330
4 Fazakerley MW, Mcgowan p, Hardy P, et al. A compar atives study of cephradion, amoxycillin and phenoxymethyl penicillin in the treatment of acute densto alveolar infection. B Ritish Dental Jounal, 1993, 174 (10):359
5 Gehanno MD. Tonsillo pharyngitis:evaluation of short-tem treatment with cefuroxime axetil versus standard 10-day penicillin Ⅴ therapy. Br J Clin Pract, 1995, 49(1):28
6 Gordon still MD, Hubbard MD, James M, et al. Comparison of clarithromy cin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available altemative antibiotic the rapies. Pediatr Infect Dis J, 1993, 12(12 suppl 13):S 134
7 Stjemquist Desatnik A, Samuelsson P ;Walder M. Penetration of penicillin Ⅴ to tonsillar surface fluid in healthy individul. J Layngol Otol, 1993, 107(4):309
8 Lewis MAO, Camichael F, Maefarlane TW, et al. Ar andomised trial of co-amo xiclav ve rsus penicillin Ⅴ in the treatment of dentoalveo larabscess. Br Dent J, 1993, 175(5):169
9 Lucia Pacifico MD, Fulvio Nanni MD, Graziellao refici MD. Recurrent Attacks of Scarlet Fever. Arch pediatr adole scmedical, 1994, 148:656
10 Weber K, Wilske B, Preac-mursic Ⅴ, et al. Azithromy cinversus penicillin Ⅴ for the treatment of early lymebor reliosis. Infection, 1993, 21(6):367
11 Goldw ater PN Dr. Primar y mening oco ccal pneum onia in a nine teen-month-old child. Pediatr Infection Dis J, 1995, 14(2):155
12 Adnan Dajani MD, Kathryn taubert phD, Patricia Ferrieri MD, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever:A statement for health professional. Pediatrics, 1995, 96(4):758
13 Prellner K, Fogle-Hansson M, Jorgensen F, et al. Prevention of recurrent acuteotitis media in otitis-prone childr en by intemittent prophylax is with penicillin. Acta Otolaryngol Slockh, 1994, 114(2):182
14 Rune SJ, Justesen T, Moller Hansen J, et al. Prevention of duodenalulcer recurrente wit hpenicillin. Scand J Gastro, 1993, 28(5):438
15 Ernest MD, Laurence B, Givner MD. A prospective, randomized, placebo-con trolled trial of penicillin in pretem premature repture of membranes. Am J Obstet Gynecol, 1994, 170(2):516
16 Anne M, Heikkila MD, Erkkola MD. The need for adjustment of dosage regimen of penicillin Ⅴ during pregnancy. Obstet rics ＆ Gyneocology, 1993, 81(6):919
17 Bolme P, Eriksson M, Paalzow L, et al. Mamutrition and phamacokinetics of penicillin in Ethiopian children. Phamacology and Toxicology, 1995, 76(4):259
18 Adnan S, Susan L, Robert M. Cefpodox imeproxe tilvs penicillin Ⅴ in pediatric strepto coccol pharyngitis/ tonsillitis. Pediatrics Infect Dis J, 1993, 12(4):275
19 Leonard W, Howard J, Jill M, et al. Dur ation of positive throat cultures for group A streto cocci after initiation of antibiotic therapy. Pediatrics, 1993, 91(6):1166
20 Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis placebo controlled double blinde valuation of clinical response to penicillin therapy. JAMA, 1985, 253: 1271
21 Lampe RM, Goodman R, Shoemaker M, et al. Duration of group A streptococcal antigen in the pharynx of patients with group A streptococcal pharyngitis. American Academy of Pediatrics. Poster session, 1985: 10:19
22 Adam D. 5-day cefixime therapy for bacterial pharyngitis and (or)tonsillitis:Comparison with 10-day penicillin Ⅴ therapy. Infection, 1995, 23(suppl):2S83
23 Stigholm, Claes hemming, Evagrahn, et al. Is penicillin the appropriate treatment for recurrent tonsill pharyngitis ?Results from a comparative randomizel blind study of cefuroxime axetil and phenoxyme thylpenicillinin childre. Scand J Infectdis, 1995:27(3):221
24 Itzhak Brook MD, Alan E, Gober MD. Role of bacterial interference and β-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck surg, 1995, 121:1405
25 Krcmery V, Trupl J. Bacteraemia due to penicillin-resistant strptococcus viridans in cancer patients, before and after prophylaxis with penicillin. The Lancet, 1995, 18:1362
26 Anders Osterlund MD. Are penicillin treatment failures in arcanobacterium haemolyticum pharyngotonsillitis caused by intracellularly residing bacteria ?Scand J Infect Dis, 1995, 27(2):131
27 王高峰.口服耐酸稳定的抗感染新药青霉素Ⅴ. 海南 医学, 1996, (2):136
28 车华, 沙怀.青霉素Ⅴ片剂口服安全性及临床疗效评 价.中国药房.1996, 7(2):81
29 Jennifer Martin MB, George Abbott MD. Serum sickness like illness and antimicrobials in children. NZ Med J, 1995;108(997):123
30 Javier Onate, Miguel Montejo, Koldo Agurrebengoa, et al. Hepatotoxicity associated with penicillin Ⅴ therapy. Clinical Infectious Diseases, 1995, 20:474 |
